@rogercrumpton - Check with your doctor but this is what I found:

Votrient (pazopanib) is a targeted cancer medication used to treat advanced renal cell carcinoma (kidney cancer) and advanced soft tissue sarcoma in adults. It works by blocking specific proteins (tyrosine kinases) involved in tumor growth and blood vessel formation (angiogenesis), including VEGFR, PDGFR, and FGFR.

Key Information:
Mechanism of Action: Votrient is a multi-targeted receptor tyrosine kinase inhibitor that inhibits tumor growth and angiogenesis by blocking key enzymes like VEGFR, PDGFR, and cKIT.
Approved Uses:
First-line treatment for advanced renal cell carcinoma (RCC).
Treatment of advanced soft tissue sarcoma in patients previously treated with chemotherapy.